Abstract
Viral myocarditis can present as dramatic heart failure in the young, and chronic indolent cardiomyopathy in the older adult. The outcome of the disease is still poor, associated with high mortality during long-term follow-up. Enteroviral myocarditis serves as an excellent model to understand virus and host interactions. The virus enters the target cells via collaborating receptors, and this process triggers an inflammatory response in the host. The immune reaction is a two-edged sword, with appropriate activation of the immune system capable of clearing the virus, but excessive activation leads to a chronic inflammatory process that triggers the remodeling of the heart and consequent clinical heart failure. Through genetic dissection strategies, we have identified that the acquired immune system is activated through the T cell receptor and signaling amplification systems, such as the tyrosine kinase p56lck, phosphatase CD45 and downstream ERK1/2, and the family of cytokines. This signaling system not only promotes inflammatory cell clonal expansion but paradoxically also promotes viral proliferation. The innate immune system is now recognized as playing an ever-expanding role in coordinating the host immune response through the Toll-like receptors, triggering downstream signaling adaptors such as MyD88, IRAK, and TRIF/IRFs. These lead to activation of cytokines or interferons, depending on the balance of the signal contributions. The ongoing research in this area should help us to understand the immune response of the heart to viral infection, while identifying potential targets for therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ (1987) Myocarditis, a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14
Ayach B, Fuse K, Martino T, Liu P (2003) Dissecting mechanisms of innate and acquired immunity in myocarditis. Curr Opin Cardiol 18:175–181
Bachmaier K, Neu N, Pummerer C, Dunca GS, Mak TW, Matsuyama T, Penninger JM (1997) iNOS expression and nitrotyrosine formation in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 96:585–591
Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
Chow LH, Radio SJ, Sears TD, McManus BM (1989) Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 14:915–920
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583–1585
Dai WJ, Bartens W, Kohler G, Hufnagel M, Kopf M, Brombacher F (1997) Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-gamma receptordeficient mice. J Immunol 158:5297–5304
Dangl J (1998) Innate immunity. Plants just say NO to pathogens. Nature 394:525
Dec GW, Fallon JT, Southern JF, Palacios I (1990) Borderline myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol 15:283–289
Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540–3543
Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR (2003) IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170:4731–4737
Godeny EK, Gauntt CJ (1987) In situ immune autoradiographic identification of cells in heart tissues of mice with Coxsackievirus B3-induced myocarditis. Am J Pathol 129:267–276
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745
Henke A, Huber S, Stelzner A, Whitton JL (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720–6728
Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffith E, Krawczyk C, Richardson CD, Aitken K, Iscove N, Koretzky G, Johnson P, Liu P, Rothstein DM, Penninger JM (2001) CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 409:349–354
Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC (1990) The detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by the polymerase chain reaction. Circulation 82:8–16
Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264:1921–1924
Kishimoto C, Abelmann WH (1990) In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice. Immature but antigenspecific T cells aggravate cardiac injury. Circ Res 67:589–598
Kishimoto C, Kuribayashi K, Fukuma K, Masuda T, Tomioka N, Abelmann WH, Kawai C (1987) Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis. Circ Res 61:715–725
Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH (1988) Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation 77:645–653
Lange LG, Schreiner GF (1994) Immune mechanisms of cardiac disease. N Engl J Med 330:1129–1135
Liu P, Mason J (2001) Advances in the understanding of myocarditis. Circulation 104:1076–1082
Liu P, Wang E, Sole M (1993) Pathology and pathogenesis of myocarditis: A 1990’s perspective. Cardiovasc Pathol 2:247–257
Liu P, Martino T, Opavsky A, Penninger J (1996) Myocarditis-balance between viral infection and immune response. Can J Cardiol 12:935–943
Liu P, Aitken K, Kong YY, Martino T, Dawood F, Wen WH, Opavsky MA, Kozieradzki I, Bachmaier K, Straus D, Mak T, Penninger J (2000) Essential role for the tyrosine kinase p56lck in coxsackievirus B3 mediated heart disease. Nat Med 6:429–434
Liu PP, Opavsky MA (2000) Viral myocarditis: Receptors that bridge that immune with the cardiovascular systems. Circ Res 86:253–254
Liu PP, Le J, Nian M (2001) NF-kB Decoy: targeting the heart of inflammatory heart disease. Circ Res 89:850–852
Martino T, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain K, Willis N, Gauntt CJ, Liu PP (2000) The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all 6 serotypes of coxsackievirus group B, and by swine vesicular disease virus. J Virol 271:99–108
Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP (1998) Cardiovirulent coxsackieviruses and the decayaccelerating factor (CD55) receptor. Virology 244:302–314
Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, Investigators MTT (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269–275
Matsumori A, Crumpacker CS, Abelmann WH (1987) Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model. J Am Coll Cardiol 9:1320–1325
Matsumori A, Tomioka N, Kawai C (1988) Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J 115:1229–1232
Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72:561–566
Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Taniguchi T, Mak TW(1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83–97
Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller AB, Pauschinger M, Bergelson J, Warraich R, Yacoub M, Hetzer R, Lamers J, Schultheiss HP, Poller W (2001) Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104:275–280
Opavsky MA, Penninger J, Aitken K, Wen WH, Dawood F, Mak T, Liu P (1999) Susceptibility to myocarditis is dependent on the response of ab T lymphocytes to coxsackieviral infection. Circ Res 85:551–558
Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson CD, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561–1569
Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348–1354
Satoh M, Nakamura M, Akatsu T, Iwasaka J, Shimoda Y, Segawa I, Hiramori K (2003) Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis. Clin Sci 104:577–584
Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Takaku F, Yazaki Y (1991) Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 84:788–795
Seko Y, Matsuda H, Kato K, Hashimoto Y, Yagita H, Okumura K, Yazaki Y (1993) Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest 91:1327–1336
Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD (1995) Coxsackievirus B1, B3 and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69:3873–3877
Sin JI, Sung JH, Suh YS, Lee AH, Chung JH, Sung YC (1997) Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene. Vaccine 15:1827–1833
Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC (2002) Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416:750–756
Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, Maekawa N, Takatsu H, Fujiwara H, Sekikawa K, Seishima M (2001) Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viral myocarditis in mice: a study using mice lacking TNF-alpha. Circulation 103:743–749
Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408–411
Yeh WC, Chen NJ (2003) Immunology: another toll road. Nature 424:743–748
Zoller J, Partridge T, Olsen I (1994) Interactions between cardiomyocytes and lymphocytes in tissue culture: an in vitro model of inflammatory heart disease. J Mol Cell Cardiol 26:627–638
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Liu, P., Fuse, K., Chu, G., Liu, Y., Opavsky, A. (2006). Recent Insights into the Role of Host Innate and Acquired Immunity Responses. In: Schultheiss, H.P., Kapp, J.F., Grötzbach, G. (eds) Chronic Viral and Inflammatory Cardiomyopathy. Ernst Schering Research Foundation Workshop, vol 55. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30822-9_8
Download citation
DOI: https://doi.org/10.1007/3-540-30822-9_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23971-0
Online ISBN: 978-3-540-30822-5
eBook Packages: MedicineMedicine (R0)